A Phase II Pivotal Trial to Evaluate the Safety and Efficacy of Nitrogen Mustard (NM) 0.02% Ointment Formulations in Patients With Stage I or IIA Mycosis Fungoides (MF)
Latest Information Update: 30 Jan 2024
At a glance
- Drugs Chlormethine (Primary)
- Indications Mycosis fungoides
- Focus Registrational; Therapeutic Use
- Sponsors Ceptaris Therapeutics
- 01 Jan 2024 Results of post hoc analysis Evaluating Response Trends of Chlormethine/Mechlorethamine Gel, published in the Clinical Lymphoma, Myeloma & Leukemia
- 16 Feb 2021 According to a Helsinn Therapeutics media release, it is pleased to note two recent journal publications on the use of mechlorethamine gel 0.016% as a topical treatment of early stage mycosis fungoides-type cutaneous T-cell lymphoma . The two publications are based on this study
- 26 Sep 2019 Results of re-analysis published in the Helsinn Therapeutics media release.